Prostaglandin E2 is a key factor for monocyte-derived dendritic cell maturation: Enhanced T cell stimulatory capacity despite IDO

Journal of Leukocyte Biology

Volumn 82, Issue 5, 2007, Pages 1106-1114

  Krause, Petra ^a   Singer, Eva ^b   Darley, Paula I ^c   Klebensberger, Janosch ^c   Groettrup, Marcus ^a,c   Legler, Daniel F ^a  

^a UNIVERSITY OF KONSTANZ   (Switzerland)

^b KLINIKUM KONSTANZ   (Germany)

^c UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

Cell proliferation; Chemotaxis; Vaccination

Indexed keywords

CD40 LIGAND; CYTOKINE; IDO PROTEIN; LIPOPOLYSACCHARIDE; PROSTAGLANDIN E2; PROTEIN; TOLL LIKE RECEPTOR 3; TRYPTOPHAN TRANSFER RNA LIGASE; UNCLASSIFIED DRUG; EP4 RECEPTOR; INDOLEAMINE 2,3 DIOXYGENASE; LIGAND; PROSTAGLANDIN E RECEPTOR; TLR3 PROTEIN, HUMAN;

ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CULTURE; CELL MATURATION; CELL MIGRATION; DENDRITIC CELL; ENZYME INDUCTION; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; T LYMPHOCYTE ACTIVATION; ANTIGEN PRESENTATION; CELL DIFFERENTIATION; CELL MOTION; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; T LYMPHOCYTE;

ANTIGEN PRESENTATION; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; DENDRITIC CELLS; DINOPROSTONE; GENE EXPRESSION REGULATION; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; LIGANDS; LYMPHOCYTE ACTIVATION; MONOCYTES; RECEPTORS, PROSTAGLANDIN E; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 3; TRYPTOPHAN-TRNA LIGASE;

EID: 36248944552     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0905519     Document Type: Article

References (43)

1. Sallusto, F., Schaerli, P., Loetscher, P., Schaniel, C., Lenig, D., Mackay, C. R., Qin, S., Lanzavecchia, A. (1998) Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur. J. Immunol. 28, 2760-2769.
2. Sozzani, S., Allavena, P., D'Amico, G., Luini, W., Bianchi, G., Kataura, M., Imai, T., Yoshie, O., Bonecchi, R., Mantovani, A. (1998) Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J. Immunol. 161, 1083-1086.
3. Ohl, L., Mohaupt, M., Czeloth, N., Hintzen, G., Kiafard, Z., Zwirner, J., Blankenstein, T., Henning, G., Forster, R. (2004) CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 21, 279-288.
4. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y. J., Pulendran, B., Palucka, K. (2000) Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767-811.
5. Mellman, I., Steinman, R. M. (2001) Dendritic cells: specialized and regulated antigen processing machines. Cell 106, 255-258.
6. Schuler, G., Schuler-Thurner, B., Steinman, R. M. (2003) The use of dendritic cells in cancer immunotherapy. Curr. Opin. Immunol. 15, 138-147.
7. Cerundolo, V., Hermans, I. F., Salio, M. (2004) Dendritic cells: a journey from laboratory to clinic. Nat. Immunol. 5, 7-10.
8. Banchereau, J., Palucka, A. K. (2005) Dendritic cells as therapeutic vaccines against cancer. Nat. Rev. Immunol. 5, 296-306.
9. Schadendorf, D., Ugurel, S., Schuler-Thurner, B., Nestle, F. O., Enk, A., Brocker, E. B., Grabbe, S., Rittgen, W., Edler, L., Sucker, A., Zimpfer-Rechner, C., Berger, T., Kamarashev, J., Burg, G., Jonuleit, H., Tuttenberg, A., Becker, J. C., Keikavoussi, P., Kampgen, E., Schuler, G. (2006) Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG. Ann. Oncol. 17, 563-570.
10. Morse, M. A., Coleman, R. E., Akabani, G., Niehaus, N., Coleman, D., Lyerly, H. K. (1999) Migration of human dendritic cells after injection in patients with metastatic malignancies. Cancer Res. 59, 56-58.
11. Scandella, E., Men, Y., Gillessen, S., Forster, R., Groettrup, M. (2002) Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. Blood 100, 1354-1361.
12. Luft, T., Jefford, M., Luetjens, P., Toy, T., Hochrein, H., Masterman, K. A., Maliszewski, C., Shortman, K., Cebon, J., Maraskovsky, E. (2002) Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E(2) regulates the migratory capacity of specific DC subsets. Blood 100, 1362-1372.
13. Scandella, E., Men, Y., Legler, D. F., Gillessen, S., Prikler, L., Ludewig, B., Groettrup, M. (2004) CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2. Blood 103, 1595-1601.
14. Legler, D. F., Krause, P., Scandella, E., Singer, E., Groettrup, M. (2006) Prostaglandin E2 is generally required for human dendritic cell migration and exerts its effect via EP2 and EP4 receptors. J. Immunol. 176, 966-973.
15. Kabashima, K., Sakata, D., Nagamachi, M., Miyachi, Y., Inaba, K., Narumiya, S. (2003) Prostaglandin E2-EP4 signaling initiates skin immune responses by promoting migration and maturation of Langerhans cells. Nat. Med. 9, 744-749.
16. Jonuleit, H., Kuhn, U., Muller, G., Steinbrink, K., Paragnik, L., Schmitt, E., Knop, J., Enk, A. H. (1997) Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur. J. Immunol. 27, 3135-3142.
17. Rieser, C., Bock, G., Klocker, H., Bartsch, G., Thurnher, M. (1997) Prostaglandin E2 and tumor necrosis factor α cooperate to activate human dendritic cells: synergistic activation of interleukin 12 production. J. Exp. Med. 186, 1603-1608.
18. Jefford, M., Schnurr, M., Toy, T., Masterman, K. A., Shin, A., Beecroft, T., Tai, T. Y., Shortman, K., Shackleton, M., Davis, I. D., Parente, P., Luft, T., Chen, W., Cebon, J., Maraskovsky, E. (2003) Functional comparison of DCs generated in vivo with Flt3 ligand or in vitro from blood monocytes: differential regulation of function by specific classes of physiologic stimuli. Blood 102, 1753-1763.
19. Rubio, M. T., Means, T. K., Chakraverty, R., Shaffer, J., Fudaba, Y., Chittenden, M., Luster, A. D., Sykes, M. (2005) Maturation of human monocyte-derived dendritic cells (MoDCs) in the presence of prostaglandin E2 optimizes CD4 and CD8 T cell-mediated responses to protein antigens: role of PGE2 in chemokine and cytokine expression by MoDCs. Int. Immunol. 17, 1561-1572.
20. Braun, D., Longman, R. S., Albert, M. L. (2005) A two step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic cell maturation. Blood 106, 2375-2381.
21. Mellor, A. L., Munn, D. H. (2004) IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat. Rev. Immunol. 4, 762-774.
22. Grohmann, U., Fallarino, F., Puccetti, P. (2003) Tolerance, DCs and tryptophan: much ado about IDO. Trends Immunol. 24, 242-248.
23. Zhu, L., Ji, F., Wang, Y., Zhang, Y., Liu, Q., Zhang, J. Z., Matsushima, K., Cao, Q., Zhang, Y. (2006) Synovial autoreactive T cells in rheumatoid arthritis resist IDO-mediated inhibition. J. Immunol. 177, 8226-8233.
24. Fleckner, J., Martensen, P. M., Tolstrup, A. B., Kjeldgaard, N. O., Justesen, J. (1995) Differential regulation of the human, interferon inducible tryptophanyl-tRNA synthetase by various cytokines in cell lines. Cytokine 7, 70-77.
25. Rubin, B. Y., Anderson, S. L., Xing, L., Powell, R. J., Tate, W. P. (1991) Interferon induces tryptophanyl-tRNA synthetase expression in human fibroblasts. J. Biol. Chem. 266, 24245-24248.
26. Hsu, F. J., Benike, C., Fagnoni, F., Liles, T. M., Czerwinski, D., Taidi, B., Engleman, E. G., Levy, R. (1996) Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat. Med. 2, 52-58.
27. Davis, I. D., Jefford, M., Parente, P., Cebon, J. (2003) Rational approaches to human cancer immunotherapy. J. Leukoc. Biol. 73, 3-29.
28. Figdor, C. G., De Vries, I. J., Lesterhuis, W. J., Melief, C. J. (2004) Dendritic cell immunotherapy: mapping the way. Nat. Med. 10, 475-480.
29. Sallusto, F., Lanzavecchia, A. (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J. Exp. Med. 179, 1109-1118.
30. Evel-Kabler, K., Chen, S. Y. (2006) Dendritic cell-based tumor vaccines and antigen presentation attenuators. Mol. Ther. 13, 850-858.
31. Forster, R., Schubel, A., Breitfeld, D., Kremmer, E., Renner-Muller, I., Wolf, E., Lipp, M. (1999) CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99, 23-33.
32. Van Helden, S. F., Krooshoop, D. J., Broers, K. C., Raymakers, R. A., Figdor, C. G., van Leeuwen, F. N. (2006) A critical role for prostaglandin E2 in podosome dissolution and induction of high-speed migration during dendritic cell maturation. J. Immunol. 177, 1567-1574.
33. Taylor, M. W., Feng, G. S. (1991) Relationship between interferon-γ indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J. 5, 2516-2522.
34. Murray, M. F. (2003) Tryptophan depletion and HIV infection: a metabolic link to pathogenesis. Lancet Infect. Dis. 3, 644-652.
35. Munn, D. H., Zhou, M., Attwood, J. T., Bondarev, I., Conway, S. J., Marshall, B., Brown, C., Mellor, A. L. (1998) Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281, 1191-1193.
36. Mellor, A. L., Sivakumar, J., Chandler, P., Smith, K., Molina, H., Mao, D., Munn, D. H. (2001) Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat. Immunol. 2, 64-68.
37. Hwu, P., Du, M. X., Lapointe, R., Do, M., Taylor, M. W., Young, H. A. (2000) Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. J. Immunol. 164, 3596-3599.
38. Munn, D. H., Sharma, M. D., Lee, J. R., Jhaver, K. G., Johnson, T. S., Keskin, D. B., Marshall, B., Chandler, P., Antonia, S. J., Burgess, R., Slingluff Jr., C. L., Mellor, A. L. (2002) Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 297, 1867-1870.
39. Terness, P., Chuang, J. J., Bauer, T., Jiga, L., Opelz, G. (2005) Regulation of human auto- and alloreactive T cells by indoleamine 2,3-dioxygenase (IDO)-producing dendritic cells: too much ado about IDO? Blood 105, 2480-2486.
40. Frumento, G., Rotondo, R., Tonetti, M., Damonte, G., Benatti, U., Ferrara, G. B. (2002) Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J. Exp. Med. 196, 459-468.
41. Terness, P., Bauer, T. M., Rose, L., Dufter, C., Watzlik, A., Simon, H., Opelz, G. (2002) Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J. Exp. Med. 196, 447-457.
42. Hwang, S. L., Chung, N. P., Chan, J. K., Lin, C. L. (2005) Indoleamine 2, 3-dioxygenase (IDO) is essential for dendritic cell activation and chemotactic responsiveness to chemokines. Cell Res. 15, 167-175.
43. Boasso, A., Herbeuval, J. P., Hardy, A. W., Winkler, C., Shearer, G. M. (2005) Regulation of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA- synthetase by CTLA-4-Fc in human CD4+ T cells. Blood 105, 1574-1581.